- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 281/16 - [b, f]-condensed
Patent holdings for IPC class C07D 281/16
Total number of patents in this class: 75
10-year publication summary
|
6
|
5
|
6
|
4
|
1
|
7
|
0
|
4
|
1
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2844 |
11 |
| Assembly Biosciences, Inc. | 68 |
9 |
| Indiana University Research and Technology Corporation | 800 |
7 |
| ACADIA Pharmaceuticals Inc. | 207 |
3 |
| Fermion Oy | 24 |
3 |
| AstraZeneca AB | 2962 |
2 |
| Janssen Pharmaceutica N.V. | 3610 |
2 |
| The Trustees of Columbia University in the City of New York | 3528 |
2 |
| Baruch S. Blumberg Institute | 30 |
2 |
| Drexel University | 973 |
2 |
| Pontificia Universidad Catolica de Chile | 278 |
2 |
| Teva Pharmaceutical Industries Ltd. | 842 |
2 |
| Teva Pharmaceuticals USA, Inc. | 967 |
2 |
| Sandoz AG | 1404 |
1 |
| Actavis Group PTC ehf | 506 |
1 |
| Alembic Limited | 67 |
1 |
| Alla Chem, LLC | 56 |
1 |
| Auspex Pharmaceuticals, Inc. | 208 |
1 |
| "biointegrator" Limited Liability Company (ooo "biointegrator") | 1 |
1 |
| Cadila Healthcare Limited | 323 |
1 |
| Other owners | 19 |